Effects of Bronchodilatation With Salmeterol on the Autonomic Nervous System
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2014
At a glance
- Drugs Salmeterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms ESAN
- Sponsors GlaxoSmithKline
- 07 Jun 2017 Biomarkers information updated
- 03 Feb 2014 Actual patient number changed from 34 to 32 as reported by ClinicalTrials.gov record.
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.